Al-Dawaa Medical Services Company (4163.SR)
SAR 82.7
(-2.13%)
SAR 82.7
(-2.13%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.7 Billion SAR | 4.69% |
| 2022 | 4.49 Billion SAR | 11.55% |
| 2021 | 4.03 Billion SAR | 13.73% |
| 2020 | 3.54 Billion SAR | 12.91% |
| 2019 | 3.13 Billion SAR | 4.32% |
| 2018 | 3 Billion SAR | 2.46% |
| 2017 | 2.93 Billion SAR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.86 Billion SAR | 3.24% |
| 2024 Q2 | 4.92 Billion SAR | 1.24% |
| 2023 Q4 | 4.7 Billion SAR | 3.25% |
| 2023 FY | 4.7 Billion SAR | 4.69% |
| 2023 Q3 | 4.55 Billion SAR | -3.69% |
| 2023 Q2 | 4.73 Billion SAR | 0.14% |
| 2023 Q1 | 4.72 Billion SAR | 5.12% |
| 2022 Q2 | 4.82 Billion SAR | 11.5% |
| 2022 FY | 4.49 Billion SAR | 11.55% |
| 2022 Q4 | 4.49 Billion SAR | -2.72% |
| 2022 Q3 | 4.62 Billion SAR | -4.15% |
| 2022 Q1 | 4.32 Billion SAR | 7.31% |
| 2021 Q1 | - SAR | -100.0% |
| 2021 FY | 4.03 Billion SAR | 13.73% |
| 2021 Q4 | 4.03 Billion SAR | 0.0% |
| 2021 Q2 | 3.72 Billion SAR | 0.0% |
| 2020 Q1 | - SAR | 0.0% |
| 2020 Q3 | 3.54 Billion SAR | 0.0% |
| 2020 Q4 | 3.54 Billion SAR | 0.0% |
| 2020 FY | 3.54 Billion SAR | 12.91% |
| 2019 FY | 3.13 Billion SAR | 4.32% |
| 2018 FY | 3 Billion SAR | 2.46% |
| 2017 FY | 2.93 Billion SAR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Middle East Pharmaceutical Industries Co. | 444.89 Million SAR | -958.103% |
| Nahdi Medical Company | 5.37 Billion SAR | 12.359% |
| Al-Razi Medical Co. | 45.41 Million SAR | -10264.9% |
| Almujtama Alraida Medical Co. | 441.99 Million SAR | -965.049% |